HutchMED (China) LIMITED Income (Loss) from Equity Method Investments
HutchMED (China) LIMITED (HCM) reported Income (Loss) from Equity Method Investments of $22.65 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-05.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-03-05
- HutchMED (China) LIMITED income (loss) from equity method investments for the quarter ending 2019-12-31 was $10.19M, a 23.05% increase year-over-year.
- HutchMED (China) LIMITED income (loss) from equity method investments for the quarter ending 2019-09-30 was $3.20M.
- HutchMED (China) LIMITED income (loss) from equity method investments for the quarter ending 2019-06-30 was $10.20M, a 27.16% increase year-over-year.
- HutchMED (China) LIMITED income (loss) from equity method investments for the quarter ending 2019-03-31 was $17.11M, a 13.84% increase year-over-year.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $22.65M 20-F · filed 2026-03-05 | |||
| 2025-06-30 | $23.13M 6-K · filed 2025-08-07 | |||
| 2024-12-31 | $46.47M 20-F · filed 2026-03-05 | |||
| 2024-06-30 | $33.81M 6-K · filed 2025-08-07 | |||
| 2023-12-31 | $47.30M 20-F · filed 2026-03-05 | |||
| 2023-06-30 | $35.11M 6-K · filed 2024-07-31 | |||
| 2022-12-31 | $49.75M 20-F · filed 2025-03-19 | |||
| 2022-06-30 | $33.55M 6-K · filed 2023-07-31 | |||
| 2021-12-31 | $60.62M 20-F · filed 2024-02-28 | |||
| 2021-06-30 | $42.97M 6-K · filed 2022-08-01 | |||
| 2020-12-31 | $79.05M 20-F · filed 2023-02-28 | |||
| 2020-06-30 | $30.37M 6-K · filed 2021-07-28 | |||
| 2019-12-31 | $10.19M derived: 20-F 12 month − 6-K 9 month · filed 2022-03-03 | $13.39M derived: sum of 2 quarters · filed 2022-03-03 | $23.59M derived: sum of 3 quarters · filed 2022-03-03 | $40.70M 20-F · filed 2022-03-03 |
| 2019-09-30 | $3.20M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | $13.40M derived: sum of 2 quarters · filed 2020-07-30 | $30.51M 6-K · filed 2020-01-21 | $38.79M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-06-30 | $10.20M derived: 6-K 6 month − 6-K 3 month · filed 2020-07-30 | $27.31M 6-K · filed 2020-07-30 | $35.59M derived: sum of 3 quarters · filed 2021-03-04 | $23.59M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-03-31 | $17.11M 6-K · filed 2019-06-06 | $25.39M derived: sum of 2 quarters · filed 2021-03-04 | $13.39M derived: sum of 3 quarters · filed 2021-03-04 | $21.41M derived: sum of 4 quarters · filed 2021-03-04 |
| 2018-12-31 | $8.28M derived: 20-F 12 month − 6-K 9 month · filed 2021-03-04 | -$3.72M derived: sum of 2 quarters · filed 2021-03-04 | $4.30M derived: sum of 3 quarters · filed 2021-03-04 | $19.33M 20-F · filed 2021-03-04 |
| 2018-09-30 | -$12.00M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | -$3.98M derived: sum of 2 quarters · filed 2020-01-21 | $11.05M 6-K · filed 2020-01-21 | |
| 2018-06-30 | $8.02M derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | $23.05M 6-K · filed 2019-07-30 | ||
| 2018-03-31 | $15.03M 6-K · filed 2019-06-06 | |||
| 2017-12-31 | $33.65M 20-F · filed 2020-03-03 | |||
| 2017-06-30 | $22.27M 6-K · filed 2018-07-27 | |||
| 2016-12-31 | $66.24M 20-F · filed 2019-03-11 | |||
| 2016-06-30 | $21.25M 6-K · filed 2017-07-31 | |||
| 2015-12-31 | $22.57M 20-F · filed 2018-03-12 | |||
| 2014-12-31 | $15.18M 20-F · filed 2017-03-13 |